Mevia provides a real-time medication adherence solution using IoT-enabled devices, Mepill and Medose, which automatically track and report when doses are taken. This technology enhances patient support and data management in clinical trials, ensuring accurate adherence monitoring and timely intervention when necessary.
Funding
$287.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In clinical trials, accurately tracking patient medication adherence is challenging, often relying on patient self-reporting or infrequent manual checks, which can lead to inaccurate data and compromised study results. Existing methods lack real-time visibility into dosing behavior, hindering timely intervention and personalized support for patients struggling with adherence.
Solution
Mevia offers a real-time medication adherence monitoring solution using IoT-enabled devices, Mepill and Medose, that automatically track and report when doses are taken. These cellular-connected devices attach to medication packages and transmit dosing data to a digital dashboard, providing administrators with real-time insights into patient adherence. The platform enables timely intervention and customized support through an integrated application or SMS setup, ensuring accurate data collection and improved patient outcomes in clinical trials. Mevia's solution facilitates proactive management of adherence behaviors and allows for the extraction of customized reports for accessible data sharing.
Target Audience
Mevia's primary customers are pharmaceutical companies, clinical research organizations, and healthcare providers conducting clinical trials who require accurate, real-time medication adherence data.
Features
- Mepill: IoT device for single pill-blister adherence tracking.
- Medose: IoT device for multiple dose-dispenser adherence tracking.
- Real-time adherence data collection via cellular connectivity.
- Digital dashboard for viewing and analyzing adherence data.
- Integrated application and SMS setup for treatment support and data collection.
- Automated dose updates in the application based on device data.
- Customizable PDF reports for data sharing.